Table 3.

Effect of lansoprazole (15 and 30 mg/kg SC) and albendazole (5 and 10 mg/kg/day, oral) treatment on HOMA parameters in type 2 diabetic rats [median (IQR)].

Parameters	Healthycontrol	Diabetescontrol	Diabetes +Low-dose Lansoprazole	Diabetes +High- dose Lansoprazole	Diabetes +Low- dose Albendazole	Diabetes +High- dose Albendazole
HOMA-IR	11.19(10.4–12.7)	26.37 #(25.9–27.8)	32.27 #(29.2–35.8)	27.45 #(16.8–38.8)	19.52 #(16.3–37.7)	21.0 #(14.0–31.0)
HOMA–β	160.4(102.5–235.8)	19.4 #(16.1–21.4)	26.5 #(22.5–27.7)	36.0 #(28.0–138.2)	78.5*(28.0–138.2)	48.03 #(25.4–73.7)

# denotes significant difference vs. healthy control group at p ˂ 0.05.* denotes significant difference vs. diabetes control group at p ˂ 0.05.